TY - JOUR
T1 - Cord blood transplantation following reduced-intensity conditioning for adult-onset inherited hemophagocytic lymphohistiocytosis
AU - Kuriyama, Takuro
AU - Kato, Koji
AU - Sakamoto, Keiji
AU - Hayashi, Masayasu
AU - Takashima, Shuichiro
AU - Mori, Yasuo
AU - Takenaka, Katsuto
AU - Iwasaki, Hiromi
AU - Teshima, Takanori
AU - Harada, Naoki
AU - Nagafuji, Koji
AU - Miyamoto, Toshihiro
AU - Akashi, Koichi
N1 - Publisher Copyright:
© 2016 The Japanese Society of Internal Medicine.
PY - 2016/3/15
Y1 - 2016/3/15
N2 - Inherited hemophagocytic lymphohistiocytosis (HLH) is a genetic anomaly disorder in which abnormally activated cytotoxic T lymphocytes cannot induce the apoptosis of target cells and antigen-presenting cells, leading to hemophagocytosis, pancytopenia, and a variety of symptoms such as a high fever. The present patient with adult-onset HLH developed refractory disease despite receiving immunosuppressive treatments. He underwent a reduced-intensity conditioning (RIC) regimen that comprised antithymocyte globulin (ATG) followed by cord blood transplantation (RIC-CBT). He achieved and maintained a complete donor type. The incorporation of ATG into RIC-CBT may prevent graft failure and control hemophagocytosis, however, further efforts are necessary to reduce infectious complications.
AB - Inherited hemophagocytic lymphohistiocytosis (HLH) is a genetic anomaly disorder in which abnormally activated cytotoxic T lymphocytes cannot induce the apoptosis of target cells and antigen-presenting cells, leading to hemophagocytosis, pancytopenia, and a variety of symptoms such as a high fever. The present patient with adult-onset HLH developed refractory disease despite receiving immunosuppressive treatments. He underwent a reduced-intensity conditioning (RIC) regimen that comprised antithymocyte globulin (ATG) followed by cord blood transplantation (RIC-CBT). He achieved and maintained a complete donor type. The incorporation of ATG into RIC-CBT may prevent graft failure and control hemophagocytosis, however, further efforts are necessary to reduce infectious complications.
UR - http://www.scopus.com/inward/record.url?scp=84960949703&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84960949703&partnerID=8YFLogxK
U2 - 10.2169/internalmedicine.55.5241
DO - 10.2169/internalmedicine.55.5241
M3 - Article
C2 - 26984088
AN - SCOPUS:84960949703
SN - 0918-2918
VL - 55
SP - 667
EP - 671
JO - Internal Medicine
JF - Internal Medicine
IS - 6
ER -